StarkAge Therapeutics
PrivateLast Round
VC Round
May 29, 2024
Total Funding Raised
$2.27M
Company Overview
StarkAge Therapeutics is a biotechnology company that develops first-in-class senolytic antibody–drug conjugates to address age-related diseases with an initial focus on oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StarkAge Therapeutics Comparables
Compare StarkAge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cleara Biotech | 87% | |
| Deciduous Therapeutics | 86% | |
| Rubedo Life Sciences | 85% |
StarkAge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 29, 2024 | ||||
| Grant | Jan 19, 2022 |
StarkAge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Grant, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 29, 2024
$1.3M raised with Bpifrance participation.
- Jan 19, 2022
$2.27M grant received from Bpifrance.
StarkAge Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about StarkAge Therapeutics's valuation, stock price, and market status.
Is StarkAge Therapeutics a public or private company?
StarkAge Therapeutics is a private company.
What is the current stock price of StarkAge Therapeutics?
StarkAge Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is StarkAge Therapeutics worth (valuation)?
Valuation information for StarkAge Therapeutics is not publicly available.
Can I buy StarkAge Therapeutics stock?
StarkAge Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was StarkAge Therapeutics's last funding round?
StarkAge Therapeutics's most recent funding round was VC Round on May 29, 2024.
Who are the main investors in StarkAge Therapeutics?
Key investors in StarkAge Therapeutics include Bpifrance.
Will StarkAge Therapeutics IPO soon?
No public IPO plans have been announced for StarkAge Therapeutics.
How can I track StarkAge Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor StarkAge Therapeutics's secondary market activity and sign up for updates.